---
figid: PMC9399520__fphar-13-963506-g007
figtitle: Celastrol ameliorates osteoarthritis via regulating TLR2/NFKB signaling
  pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9399520
filename: fphar-13-963506-g007.jpg
figlink: /pmc/articles/PMC9399520/figure/F7/
number: F7
caption: A schematic diagram of the proposed mechanism of celastrol on TLR2/NF-κB
  signals in rat chondrocytes. Celastrol treatment negatively regulated TLR2 activation
  and NF-κB phosphorylation in IL-1β-induced chondrocytes, thereby inhibiting inflammation
  and matrix degradation.
papertitle: Celastrol ameliorates osteoarthritis via regulating TLR2/NF-κB signaling
  pathway.
reftext: Guangxia Yang, et al. Front Pharmacol. 2022;13:963506.
year: '2022'
doi: 10.3389/fphar.2022.963506
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: osteoarthritis | celastrol | innate immunity | TLR2 | NF-κB
automl_pathway: 0.9656001
figid_alias: PMC9399520__F7
figtype: Figure
redirect_from: /figures/PMC9399520__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9399520__fphar-13-963506-g007.html
  '@type': Dataset
  description: A schematic diagram of the proposed mechanism of celastrol on TLR2/NF-κB
    signals in rat chondrocytes. Celastrol treatment negatively regulated TLR2 activation
    and NF-κB phosphorylation in IL-1β-induced chondrocytes, thereby inhibiting inflammation
    and matrix degradation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NPC1
  - TLR2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - TIRAP
  - MYD88
  - COX2
  - PTGS2
  - MTCO2P12
  - MMP13
---
